The Worldwide CAR T-cell therapy market is undergoing a period of significant growth. This growth can be attributed to several factors, including the rising prevalence of blood disorders, progresses in immunotherapy, and supportive regulatory recognitions. The market is categorized by type of CAR T-cell therapy, use, phase of treatment, and territo